Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (271-280 of 459) with videos related to

Pageof 46
Sort By:
Biochimica Et Biophysica Acta|February 1, 2014
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinomaMatteo Santoni, Francesco Pantano, Consuelo Amantini, et al.
Future Oncology (London, England)|July 11, 2015
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinomaAlessandro Bittoni, Francesco Piva, Matteo Santoni, et al.
World Journal of Urology|December 24, 2015
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patientsAlessandro Conti, Matteo Santoni, Luciano Burattini, et al.
Oncotarget|October 10, 2015
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinomaFrancesco Piva, Matteo Giulietti, Giulia Occhipinti, et al.
Cancers|June 19, 2019
Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by TumorVeronica Mollica, Vincenzo Di Nunno, Lidia Gatto, et al.
Cancers|February 25, 2022
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?Andrea Marchetti, Matteo Rosellini, Giacomo Nuvola, et al.
Targeted Oncology|January 31, 2015
The route to personalized medicine in bladder cancer: where do we stand?Francesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
The Prostate|May 26, 2026
Prognostic Role of Serum Neuron-Specific Enolase at Baseline and its Early Dynamics in Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Signaling InhibitorsOndřej Fiala, Michaela Tkadlecová, Zuzana Váchalová, et al.
Clinical Genitourinary Cancer|December 4, 2014
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancerMatteo Santoni, Simon J Crabb, Alessandro Conti, et al.
Clinical Genitourinary Cancer|March 30, 2016
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With EverolimusVincenza Conteduca, Matteo Santoni, Matelda Medri, et al.
Pageof 46

Showing results (271-280 of 459) with videos related to

Sort By:
Pageof 46
Biochimica Et Biophysica Acta|February 1, 2014
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinomaMatteo Santoni, Francesco Pantano, Consuelo Amantini, et al.
Future Oncology (London, England)|July 11, 2015
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinomaAlessandro Bittoni, Francesco Piva, Matteo Santoni, et al.
World Journal of Urology|December 24, 2015
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patientsAlessandro Conti, Matteo Santoni, Luciano Burattini, et al.
Oncotarget|October 10, 2015
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinomaFrancesco Piva, Matteo Giulietti, Giulia Occhipinti, et al.
Cancers|June 19, 2019
Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by TumorVeronica Mollica, Vincenzo Di Nunno, Lidia Gatto, et al.
Cancers|February 25, 2022
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?Andrea Marchetti, Matteo Rosellini, Giacomo Nuvola, et al.
Targeted Oncology|January 31, 2015
The route to personalized medicine in bladder cancer: where do we stand?Francesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
The Prostate|May 26, 2026
Prognostic Role of Serum Neuron-Specific Enolase at Baseline and its Early Dynamics in Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Signaling InhibitorsOndřej Fiala, Michaela Tkadlecová, Zuzana Váchalová, et al.
Clinical Genitourinary Cancer|December 4, 2014
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancerMatteo Santoni, Simon J Crabb, Alessandro Conti, et al.
Clinical Genitourinary Cancer|March 30, 2016
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With EverolimusVincenza Conteduca, Matteo Santoni, Matelda Medri, et al.
Pageof 46